Hodgkin's Disease, Clinical Stages I and II Results of radical irradiation with or without chemotherapy

References

• Andrieu J. M., Bayle‐Weisgerber C., Boiron M., Briere J. F., Clot P., Dana M., Jacquillat C., Katz M., Teillet F. Chemotherapy‐radiotherapy sequence in the management of Hodgkin's disease. Results of a clinical trial. Europ. J. Cancer 1979; 15: 153
   Web of Science ®Google Scholar
• Arseneau J. C., Canellos G. P., Johnson R., De Vita V. T. Risk of new cancers in patients with Hodgkin's disease. Cancer 1977; 40: 1912
   PubMed Web of Science ®Google Scholar
• Aubertin J., Lacut J. Y., Hoerni B., Durand M. Opportunistic infections in cancer patients. Masson, New York 1978; Vol. 1
   Google Scholar
• Bernadou A., Blanc C. M., James J. M., Dao C., Zittoun R., Bilski‐Pasquier G. Maladie de Hodgkin. Valeur des critères dits de prognostic et de l'association radio‐chimiothérapique dans les stades lymphoïdes localisés (I et II). 94 malades laparotomisés. Nouv. Presse méd. 1978; 7: 807
   Google Scholar
• Brody R. S., Schottenfeld D., Reid A. Multiple primary cancer risk after therapy for Hodgkin's disease. Cancer 1977; 40: 1917
   PubMed Web of Science ®Google Scholar
• Chapman R. M., Sutcliffe S. B., Rees L. H., Edwards C. R. W., Malpas J. S. Cyclical combination chemotherapy and gonadal function. Retrospective study in males. Lancet 1979; I: 285
   Google Scholar
• Chauvergne J., Horni B., Hoarni‐Simon G., Durand M., Lagarde C. Chimiothérapie de la maladie de Hodgkin associant procarbazine, vinblastine, cyclophosphamide et méthyl‐prednisolone. Analyse d'un série de 124 cures. Z. Krebforsch. 1973; 80: 179
   Google Scholar
• De Vita V. T., Jr. Hodgkin's disease. The salvage of radiation treatment failures. Int. J. Radiat. Oncol. Biol. Phys. 1977; 2: 1035
   PubMed Web of Science ®Google Scholar
• De Vita V. T., Jr, Serpick A. A., Carbone P. P. Combination chemotherapy in the treatment of advanced Hodgkin's disease. Ann. intern. Med. 1970; 73: 881
   PubMed Web of Science ®Google Scholar
• Easson E. C. Long‐term results of radical radiotherapy in Hodgkin's disease. Cancer Res. 1966; 26: 1244
   PubMed Web of Science ®Google Scholar
• Editorial. Staging laparotomy for Hodgkin's disease. Reassessment. Lancet 1978; II: 875
   Google Scholar
• Echbali H., Hoerni‐Simon G., Durand M., Chauvergne J., Touchard J., Hoerni B. Hodgkin's disease treated by chemotherapy and large field irradiation. Hematologic effects. Acta radiol. Oncology 1978; 17: 289
   Google Scholar
• EORTC Radiotherapy/Chemotherapy Group. A randomized study of irradiation and vinblastine in stages I and II of Hodgkin's disease. Preliminary results. Europ. J. Cancer 1972; 8: 353
   Web of Science ®Google Scholar
• Griffin T., Gerdes A., Parker R., Taylor E., Haferman M., Taylor W., Tesh D. Are pelvic irradiation and routine staging laparotomy necessary in clinically stages IA and IIA Hodgkin's disease?. Cancer 1977; 40: 2914
   PubMed Web of Science ®Google Scholar
• Henry P., Castaings G., Hœrni B., Touchard J. La myélopathie progressive post‐radiothérapique tardive. J. Neurol. Sci. 1971; 14: 325
   PubMedGoogle Scholar
• Hoearni B., Chauvergne J., Lagarde C. The strategy of treatment of Hodgkin's disease. Recent result in cancer research, G. Mathé. Springer, Berlin 1977; Vol. 62: 110
   Google Scholar
• Kadin M. E., Glatstein E., Dorfman R. F. Clinicopathological studies of 117 untreated patients subjected to laparotomy for the staging of Hodgkin's disease. Cancer 1971; 27: 1277
   PubMed Web of Science ®Google Scholar
• Kaplan H. S. Long‐term results of palliative and radical radiotherapy of Hodgkin's disease. Cancer Res. 1966; 26: 1250
   PubMed Web of Science ®Google Scholar
• Krikorian J. G., Burke J. S., Rosenberg S. A., Kaplan H. S. Occurrence of non‐Hodgkin's lymphoma after therapy for Hodgkin's disease. New Engl. J. Med. 1979; 300: 452
   PubMed Web of Science ®Google Scholar
• Lagarde C., Chauvergne J., Durand M., Horni B., Hœrni‐Simon G., Touchard J. Intérèt d'une chimiothérapie complémentaire de la radiothérapie dans les stades I et II de la maladie de Hodgkin. Bull. Cancer 1975; 62: 1
   PubMedGoogle Scholar
• Lukes R. J., Craver L. F., Hall T. C., Rappaport H., Ruben P. Report of the nomenclature committee. Cancer Res. 1966; 26: 1311
   Web of Science ®Google Scholar
• Peto R., Pike M. C., Armitage P., Breslow N. E., Cox D. R., Howard S. V., Mantel N., McPherson K., Peto J., Smith P. G. Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. Analysis and examples. Brit. J. Cancer 1977; 35: 1
   PubMed Web of Science ®Google Scholar
• Prosnitz L. R. Radiation doses following intensive chemotherapy in the treatment of Hodgkin's disease. Int. J. Radiat. Oncol. Biol. Phys. 1976; 1: 803
   PubMed Web of Science ®Google Scholar
• Rosenberg R. A., Kaplan H. S. The management of stages I and II of Hodgkin's disease with combined radiotherapy and chemotherapy. Cancer 1975; 35: 55
   PubMed Web of Science ®Google Scholar
• Rosenberg R. A., Kaplan H. S., Glatstein E. J., Portlock C. S. Combined modality therapy of Hodgkin's disease. A report on the Stanford trials. Cancer 1978; 42: 991
   PubMed Web of Science ®Google Scholar
• Symposium. Obstacles in the control of Hodgkin's disease. Cancer Res. 1966; 26: 1046
   Web of Science ®Google Scholar
• Symposium. La radiothérapie de la maladie de Hodgkin. Nouv. Rev. franç. Hémat. 1966; 6: 1
   Google Scholar
• Tubiana M., Henry‐Amar M., Hayat M., Breur K., van der Were‐Messing B., Burges M. Long‐term results of the EORTC randomized study of irradiation and vinblastine in clinical stages I and II of Hodgkin's disease. Europ. J. Cancer 1979; 15: 645
   PubMed Web of Science ®Google Scholar
• Weller S. A., Glatstein E. J., Kaplan H. S., Rosenberg S. A. Initial relapses in previously treated Hodgkin's disease. I. Results of second treatment. Cancer 1976; 37: 2840
   PubMed Web of Science ®Google Scholar